Skip to content

Azenta

US · AZTA #2893 by market cap Listed 1970
44.80 -2.29 -4.86%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions increased by 27 in the most recent period (2026/Q3).
  • Total institutional ownership rose 8.0 percentage points.

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
123.35% +7.95pp
Institutions
329 +27
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund88.02%
Hedge Fund23.62%
Public Company6.35%
Government Pension Fund2.10%
Insurance Company1.30%
Private Company1.29%
Individual/Insider0.70%
Sovereign Wealth Fund0.52%

Top holders as of 2026-09-30

BlackRock 16.81% · 7.02M sh
Politan Capital Management, L.P. 11.07% · 4.62M sh
Vanguard Portfolio Management, LLC 5.83% · 2.43M sh
State Street Global Advisors 4.07% · 1.78M sh
Vanguard Capital Management, LLC 4.17% · 1.74M sh
MFS Investment Management 3.41% · 1.42M sh
D. E. Shaw & Co., L.P. 3.21% · 1.34M sh
Front Street Capital Management, Inc. 3.12% · 1.30M sh
Dimensional Fund Advisors 2.87% · 1.20M sh
Morgan Stanley 2.74% · 1.15M sh
Allspring Global Investments, LLC 2.72% · 1.19M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 38 buys · 12 sells

NameRoleStake
Politan Capital Management, L.P. -- 11.07%
Martin Madaus Interim President, CEO & Director 0.10%
Robyn Davis Independent Vice Chair of the Board 0.10%
John P. Marotta Former Chief Executive Officer 0.09%
Lawrence Lin Chief Financial Officer 0.06%
Erica McLaughlin Independent Director 0.05%
Frank Casal Independent Chairperson 0.05%
William Cornog Independent Director 0.05%
Alan Malus Former Independent Director 0.04%
Tina Nova Independent Director 0.04%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-10-21 Martin Madaus Interim President, CEO & Director Sale to Issuer -1,294 $36.01
2026-09-21 Martin Madaus Interim President, CEO & Director Sale to Issuer -1,456 $34.28
2026-09-14 Erik Bello Vice President, Chief Accounting Officer & Principal Accounting Officer Other Acquisition +4,586 --
2026-09-13 Martin Madaus Interim President, CEO & Director Other Acquisition +36,653 --
2026-09-13 Ephraim Starr Senior Vice President Other Acquisition +15,272 --
2026-09-13 Olga Pirogova Senior VP & Chief HR Officer Other Acquisition +15,272 --
2026-09-13 William Martin Senior Vice President & President of Multiomics Other Acquisition +15,272 --
2026-09-13 Lawrence Lin Chief Financial Officer Other Acquisition +30,544 --
2026-08-08 Olga Pirogova Senior VP & Chief HR Officer Sale to Issuer -1,085 $32.04
2026-07-30 Ephraim Starr Senior Vice President Private Acquisition +335 $24.17
2026-05-17 William Cornog Independent Director Open Market Acquisition +10,000 $16.38
2026-05-14 Ephraim Starr Senior Vice President Sale to Issuer -3,621 $16.02
2026-04-27 William Martin Senior Vice President & President of Multiomics Other Acquisition +17,790 $24.24
2026-02-05 Tina Nova Independent Director Other Acquisition +5,663 $27.85
2026-02-04 Martin Madaus Interim President, CEO & Director Other Derivative Acquisition +5,663 --
2026-02-04 Robyn Davis Independent Vice Chair of the Board Other Derivative Acquisition +5,663 --
2026-02-04 Erica McLaughlin Independent Director Other Acquisition +5,663 $27.85
2026-02-04 Dipal Doshi Independent Director Other Acquisition +5,663 $27.85
2026-02-04 Frank Casal Independent Chairperson Other Acquisition +7,243 $27.85
2026-02-04 Quentin Koffey Independent Director Other Acquisition +5,663 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Azenta discussion 0 comments

Add a comment